Research by Grant Title

Title, Institution Investigator Award Cycle Award [sort]
(-) Lobeline: total synthesis and derivitization 2002 (Cycle XI) $60,000
California Institute of Technology Jeffrey Bagdanoff B.S.
11th National Conference on Nicotine Dependence 1998 (Cycle VII) $12,000
American Society of Addiction Medicine Lori Karan M.D.
16S rRNA PhyloChip Analysis of Bacterial Communities in COPD 2008 (Cycle XVII) $75,000
University of California, San Francisco Yvonne Huang M.D.
2nd East West Conference on Tobacco and Alcohol 2005 (Cycle XIV) $15,000
University of Southern California Andy Johnson
2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth 1995 (Cycle IV) $149,221
The Burnham Institute for Medical Research Hudson Freeze Ph.D.
50000 Fold Signal Enhancement for Imaging Vulnerable Plaque 2007 (Cycle XVI) $213,845
Huntington Medical Research Institute Pratip Bhattacharya Ph.D.
A dynamic model of smoking and healthcare expenditures in CA 2000 (Cycle IX) $595,843
University of California, San Francisco Wendy Max Ph.D.
A longitudinal study of smoking transitions in youth 1999 (Cycle VIII) $577,574
University of California, San Diego Elizabeth Gilpin M.S.
A Methodological Multi-Ethnic Study of Smoking Initiation 1995 (Cycle IV) $260,978
University of California, Los Angeles Celia Kaplan DrPH
A mindfulness-based approach to relapse prevention 2005 (Cycle XIV) $134,325
California Pacific Medical Center Research Institute Cassandra Vieten Ph.D.
A model system for smoking-related damage to proteins 1999 (Cycle VIII) $75,375
J. David Gladstone Institutes Johan Bjorkegren M.D., Ph.D.
A New Approach for Studying the Mechanism of Squamous Metapl 1995 (Cycle IV) $75,000
University of California, Los Angeles Sanford Barsky M.D.
A new molecular approach for predicting lung cancer 2000 (Cycle IX) $75,000
University of California, Irvine Ram Kumar Sindhu Ph.D.
A novel approach to prevent in utero nicotine lung injury 2005 (Cycle XIV) $597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center Virender Rehan M.D.
A Novel Approach to Prevent in Utero Nicotine Lung Injury 2008 (Cycle XVII) $564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center Virender Rehan M.D.
A novel FMRI smoking craving and reward paradigm 2003 (Cycle XII) $96,949
University of California, Los Angeles John Monterosso Ph.D.
A novel lung tumor suppressor 1997 (Cycle VI) $144,788
The Burnham Institute for Medical Research Steven Frisch Ph.D.
A novel therapeutic target for stroke 1997 (Cycle VI) $72,310
The Burnham Institute for Medical Research Li-Tao Zhong M.D., Ph.D.
A novel total synthesis of brazilin and brazilide A 2005 (Cycle XIV) $59,191
University of California, Santa Barbara Yaodong Huang M.S.
A novel, 3-dimensional approach to non-invasive diagnostics 2005 (Cycle XIV) $99,000
University of California, Irvine Petra Wilder-Smith D.D.S., Ph.D.
A retroviral link to human tobacco-related lung cancer? 1999 (Cycle VIII) $74,500
University of California, Los Angeles Sanford Barsky M.D.
A Smokeless Tobacco Cessation Program: High School Athletes 1995 (Cycle IV) $533,923
University of California, San Francisco Margaret Walsh MS, EdD
A stage-based scheduled smoking intervention for Chinese 2005 (Cycle XIV) $554,500
University of California, San Francisco Janice Tsoh Ph.D.
A study of Bax, a gene involved in killing tumor cells 1998 (Cycle VII) $75,060
The Burnham Institute for Medical Research Shahrzad Nouraini Ph.D.
A web-based support community as a tool for ST cessation 2003 (Cycle XII) $100,000
University of California, San Francisco Margaret Walsh MS, EdD
Acculturation & cigarette smoking among Asian-Americans 1997 (Cycle VI) $244,715
University of Southern California Xinguang Chen Ph.D.
Acculturation, media, peers, parents and adolescent smoking 1998 (Cycle VII) $213,511
University of Southern California Jennifer Unger Ph.D.
Activation and detoxification of lung cancer carcinogens 2006 (Cycle XV) $420,000
University of California, San Diego Robert Tukey Ph.D.
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle XIV) $134,074
Scripps Research Institute Asa Gustafsson Ph.D.
Activation of Bnip3 in tobacco-induced heart disease 2005 (Cycle XIV) $155,791
San Diego State University Research Foundation Asa Gustafsson Ph.D.
Activation of NF-kB by cigarette smoke 1999 (Cycle VIII) $224,217
University of California, Davis Richart Harper M.D.
Ad and Movie Imagery and Teen's Perceptions About Smokers 1995 (Cycle IV) $190,616
University of California, Irvine Cornelia Pechmann Ph.D.
Addressing Substance Abusers Who Also Smoke 1994 (Cycle III) $270,931
Northern California Institute for Research & Education Karen Sees D.O.
Adolescent susceptibility to tobacco: a panel analysis 2001 (Cycle X) $495,433
University of California, Irvine Larry Jamner Ph.D.
Adolescent Susceptibility to Tobacco: A Panel Analysis 1997 (Cycle VI) $456,076
University of California, Irvine Larry Jamner Ph.D.
African American church role in tobacco norm change 2005 (Cycle XIV) $115,098
Health Education Council Ayanna Kiburi MPH
African Americans and Mentholated Cigarettes 1999 (Cycle VIII) $417,968
Charles R. Drew University of Medicine & Science Bruce Allen DrPH
African Americans: NRT or Alternative Medicine for Cessation 2006 (Cycle XV) $285,000
University of California, San Francisco Valerie Yerger ND, MA
Aggression and Nicotine 1997 (Cycle VI) $230,326
University of California, Irvine Larry Jamner Ph.D.
Airway transcriptome changes in smokers 2004 (Cycle XIII) $99,500
University of California, San Francisco John Fahy M.D.
ALAC 2003 Annual Conference 2003 (Cycle XII) $5,000
American Lung Association of California Steve O'Kane
ALAC Annual Conference 2005 (Cycle XIV) $2,500
American Lung Association of California Lynn Devine
ALAC Annual Conference 2006 (Cycle XV) $5,000
American Lung Association of California Kerlyn Chatelain-Graham
ALAC Annual Conference 2007 (Cycle XVI) $5,000
American Lung Association of California Laura Keegan
ALAC Conference 2004 (Cycle XIII) $5,000
American Lung Association of California Laura Keegan
Allocation of Health Care to Smokers: Practice and Ethics 1998 (Cycle VII) $113,598
Stanford University Thomas Raffin M.D.
Allosteric Protein Kinase Modulators via Disulfide Trapping 2008 (Cycle XVII) $75,000
University of California, San Francisco Jack Sadowsky Ph.D.
Alpha4* Nicotinic Receptor in Dopaminergic System 2007 (Cycle XVI) $75,000
California Institute of Technology Cheng Xiao Ph.D.
Alterations in gene expression after tobacco smoke exposure 1997 (Cycle VI) $216,612
University of California, Davis Ken Yoneda M.D.
Alternative sources of ETS exposure in infants 1998 (Cycle VII) $109,687
San Diego State University Research Foundation Georg Matt Ph.D.
An athletic trainer mediated spit tobacco cessation program 1998 (Cycle VII) $490,546
University of California, San Francisco Margaret Walsh MS, EdD
An economic analysis of factors influencing teen smoking 1998 (Cycle VII) $221,497
University of California, San Diego Sherry Emery MBA, Ph.D.
An RNA biomarker for tobacco smoke toxicity 1999 (Cycle VIII) $51,751
University of California, Davis Richard Kimura
Anabolic therapies for muscle dysfunction in women with COPD 2001 (Cycle X) $632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center Richard Casaburi M.D., Ph.D.
Analysis of a candidate lung tumor suppressor gene at 3p21.3 2000 (Cycle IX) $111,910
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
Analysis of a lung tumor supressor gene at 3p21.3 2001 (Cycle X) $249,438
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
Analysis of a nicotine-related receptor binding site 1997 (Cycle VI) $69,218
University of California, San Francisco Laura England Ph.D.
Analysis of California adolescent tobacco data 2001 (Cycle X) $475,742
University of California, Los Angeles William McCarthy Ph.D.
Analysis of the Hippo pathway in lung cancer 2008 (Cycle XVII) $654,999
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
Analysis of tobacco industry documents on scientific researc 2000 (Cycle IX) $442,646
University of California, San Francisco Lisa Bero Ph.D.
Antiatherogenic helical segments of apo A-I 2004 (Cycle XIII) $141,230
Lawrence Berkeley National Laboratory John Bielicki Ph.D.
Antioxidants, cigarette smoking and atherosclerosis 1998 (Cycle VII) $730,640
University of Southern California James Dwyer Ph.D.
Antismoking slides in movie Theaters: A Naturalistic Eval 2000 (Cycle IX) $10,000
University of California, Irvine Cornelia Pechmann Ph.D.
Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing 1997 (Cycle VI) $446,947
University of California, Los Angeles Barbara Berman Ph.D.
ApoE isoforms, fatty acid metabolism and atherosclerosis 2001 (Cycle X) $691,616
J. David Gladstone Institutes Robert Pitas Ph.D.
ApoE related effect of smoking in cardiovascular disease 2008 (Cycle XVII) $630,561
Children's Hospital Oakland Research Institute Vasanthy Narayanaswami Ph.D.
Apolipoprotein E: remnant metabolism and atherogenesis 1999 (Cycle VIII) $793,474
J. David Gladstone Institutes Yadong Huang M.D., Ph.D.
Ascertainment of environmental tobacco exposure in pregnancy 1999 (Cycle VIII) $2,053,747
Sequoia Foundation Martin Kharrazi Ph.D.
Asian American and Pacific Islander (AAPI) Sci. Conf./Wkshp. 2007 (Cycle XVI) $5,000
University of California, Los Angeles Yih-Ing Hser Ph.D.
Assessing nicotine relapse in a mouse model 2001 (Cycle X) $183,804
SRI International Taline Khroyan Ph.D.
Association of Outlet Density with Smoking and Pack Price 2008 (Cycle XVII) $516,285
Stanford University Lisa Henriksen Ph.D.
Asthma, gender, and ETS: pathogenic synergy 2005 (Cycle XIV) $98,908
University of California, Davis Laurel Gershwin D.V.M., Ph.D.
BAG-1, a unique gene involved in smoking-associated cancers 1998 (Cycle VII) $75,060
The Burnham Institute for Medical Research Zhihua Xie Ph.D.
Banning Butts: The Environmental Case 2008 (Cycle XVII) $99,500
University of California, San Francisco Thomas Novotny M.D., MPH
Bayview-Hunters Point partnership toward smoking cessation 2002 (Cycle XI) $75,000
University of California, San Francisco Carol McGruder B.A.
Bayview-Hunters Point partnership toward smoking cessation 2002 (Cycle XI) $75,000
University of California, San Francisco Ruth Malone Ph.D., R.N.
Behavioral effects of neonatal nicotine exposure 2000 (Cycle IX) $624,780
San Diego State University Research Foundation Edward Riley Ph.D.
Behavioral epidemiology of tobacco use among gay men 1998 (Cycle VII) $626,433
University of California, San Francisco Greg Greenwood Ph.D.
Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro 1995 (Cycle IV) $321,199
University of California, San Diego Hyam Leffert M.D.
Bioactive lipids in tobacco related lung cancers 1997 (Cycle VI) $74,496
University of California, San Diego Jerold Chun M.D., Ph.D.
Birth defects, smoking and host susceptibility 2003 (Cycle XII) $466,200
March of Dimes Birth Defects Foundation Suzan Carmichael Ph.D.
Bispecific molecular therapy of small cell lung cancer 2001 (Cycle X) $434,805
University of California, San Diego Edward Ball M.D.
Boosting the immune response against lung cancer 1998 (Cycle VII) $70,000
University of California, Los Angeles Marina Stolina Ph.D.
Brachial Vasoreactivity in Young Adult Smokers 1997 (Cycle VI) $332,294
Osteoporosis Medical Center Jacques Barth M.D., Ph.D.
Brain adaptations to chronic nicotine expsoure 1997 (Cycle VI) $402,111
University of California, Irvine Frances Leslie Ph.D.
Brain imaging in nicotine addiction 2002 (Cycle XI) $419,881
University of California, Los Angeles Desmond Smith Ph.D.
Brain metabolic changes with cigarette craving 1998 (Cycle VII) $250,850
Brentwood Biomedical Research Institute Arthur Brody M.D.
Brain nAChR Occupancy: Effect of Secondhand Smoke 2007 (Cycle XVI) $623,841
Brentwood Biomedical Research Institute Arthur Brody M.D.
Brain wave assessment of tobacco cessation readiness 1997 (Cycle VI) $115,487
Scripps Research Institute Aaron Ilan Ph.D.
Bupropion and nicotine dependence: behavior & neurochemisty 2005 (Cycle XIV) $37,500
Scripps Research Institute Neil Paterson B.Sc., MBCh.B.
Bupropion and nicotine dependence: behavior & neurochemisty 2005 (Cycle XIV) $37,000
University of California, San Diego Neil Paterson B.Sc., MBCh.B.
Bupropion for hospital-based smoking cessation 2003 (Cycle XII) $478,065
University of California, San Francisco Joel Simon M.D., M.P.H.
Bupropion for smoking cessation 1998 (Cycle VII) $471,154
University of California, San Francisco Joel Simon M.D., M.P.H.
California AB13 compliance and ethnicity in urban bars 2003 (Cycle XII) $769,266
Pacific Institute for Research and Evaluation Roland Moore BA, MA, Ph.D.
California pharm-assists for smoking cessation 1999 (Cycle VIII) $124,689
SRI International Karen Hudmon Dr.P.H., R.P.H., M.S.
California pharm-assists for smoking cessation 1999 (Cycle VIII) $124,689
SRI International Marilyn Shreve R.Ph.
Calorigenic and Atherogenic Effects of Smoking and Nicotine 1995 (Cycle IV) $357,492
University of California, San Francisco Marc Hellerstein M.D., Ph.D.
Cambodian research initiative 2003 (Cycle XII) $106,456
California State University, Long Beach Foundation Robert Friis Ph.D.
Cambodian research initiative 2003 (Cycle XII) $106,456
California State University, Long Beach Foundation Him Chhim MS, MPA
Carbon monoxide and the brain growth spurt 1998 (Cycle VII) $464,268
University of California, Los Angeles John Edmond Ph.D.
Carbon monoxide as a modulator of myocardial function 1999 (Cycle VIII) $225,000
University of California, Davis Ulrike Kreutzer Ph.D.
Cardiac ion channels and tobacco-related disease 2002 (Cycle XI) $389,983
University of California, Santa Barbara Carol Vandenberg Ph.D.
Cardiovascular responses through spinal nicotinic receptors 2001 (Cycle X) $448,941
University of California, San Diego Palmer Taylor Ph.D.
Cardiovascular responses to nicotine 1997 (Cycle VI) $430,843
University of California, San Diego Palmer Taylor Ph.D.
Case studies of indoor air regulations: role of research 1997 (Cycle VI) $292,210
University of California, San Francisco Lisa Bero Ph.D.
Cell adhesion at nicotinic synapses 2005 (Cycle XIV) $59,454
University of California, San Diego Gallen Triana-Balzer B.A.
Cell-cell interact reg distrib of nic receptrs on neurons 2000 (Cycle IX) $29,754
University of California, San Diego Sergio Kaiser
Cellular Defects in Lung caused by Tobacco Smoke 1995 (Cycle IV) $319,013
University of California, San Francisco Alan Verkman M.D., Ph.D.
cGMP regulation of vascular smooth muscle differentiation 2005 (Cycle XIV) $403,818
University of California, San Diego Renate Pilz M.D.
Chemical synthesis of communesin B, a novel antineoplastic 2005 (Cycle XIV) $74,403
California Institute of Technology Shyam Krishnan Ph.D.
Chemokine-based therapy for lung cancer 2001 (Cycle X) $416,940
University of California, Los Angeles Sherven Sharma Ph.D.
Chemopreventive strategies against lung cancer recurrence 2000 (Cycle IX) $75,000
University of California, Los Angeles Jenny Mao M.D.
Chemotherapeutic inhibition of polysialic acid biosynthesis 2003 (Cycle XII) $420,781
University of California, Davis Jacquelyn Gervay-Hague Ph.D.
Cholesterol metabolism and atherosclerosis 1997 (Cycle VI) $74,500
University of California, San Diego Oswald Quehenberger Ph.D.
Chromatin Remodeling in Glucocorticoid Resistance of COPD 2008 (Cycle XVII) $60,000
University of California, San Francisco Karin Buser B.S.
Chronic bronchitis: pathology of mucin gene expression 2000 (Cycle IX) $329,481
University of California, Davis Walter Finkbeiner M.D., Ph.D.
Chronic bronchitis: pathology of mucin gene expression 2000 (Cycle IX) $147,758
University of California, San Francisco Walter Finkbeiner M.D., Ph.D.
Chronic CO exposure impairs the developing auditory system 2004 (Cycle XIII) $75,000
University of California, Los Angeles Douglas Webber Ph.D.
Chronic nicotine treatment in primates; role of a6b2 nAChRs 2008 (Cycle XVII) $577,128
The Parkinson's Institute Maryka Quik Ph.D.
Cigar smoking among young adults: formative research 1997 (Cycle VI) $292,920
California State University, Long Beach Foundation Fen Rhodes Ph.D.
Cigar use prevalence: social and media determinants 1997 (Cycle VI) $318,750
San Diego State University Research Foundation Joachim Reimann Ph.D.
Cigarette smoke alters lipoprotein & artery wall interaction 1997 (Cycle VI) $472,876
University of California, Los Angeles Alan Fogelman M.D.
Cigarette smoke effects on cells crucial for wound healing 2001 (Cycle X) $74,500
University of California, Riverside Manuela Martins-Green Ph.D.
Cigarette smoke effects on human vascular endothelial genes 1998 (Cycle VII) $75,000
University of California, Riverside Craig Byus Ph.D.
Cigarette smoke injures lung epithelium by activating nSMase 2008 (Cycle XVII) $394,380
University of California, Davis Tzipora Goldkorn BSc, MSc, Ph.D.
Cigarette smoke, MCP-1 expression in vivo and atherogenesis 2002 (Cycle XI) $50,418
University of California, Riverside Lina Seang Wong B.S.
Cigarette Smoking and Stress-Coping among Latino Youth 2008 (Cycle XVII) $60,000
University of Southern California Rachel Grana M.P.H.
Cigarette smoking in HIV-positive populations 2000 (Cycle IX) $74,882
University of California, San Francisco Gary Humfleet Ph.D.
Classroom animation tobacco awareness program effectiveness 2004 (Cycle XIII) $558,761
WestEd Barbara Dietsch Ph.D.
Classroom animation tobacco awareness program effectiveness 2004 (Cycle XIII) $558,761
WestEd Diane Schwartz M.A.
Clearing the Air: An Institute for Policy Advocacy, IV 2007 (Cycle XVI) $5,000
American Nonsmokers' Rights Foundation Cynthia Hallett MPH
Clearing the Air: An Institute for Policy Advocacy, V 2007 (Cycle XVI) $5,000
American Nonsmokers' Rights Foundation Cynthia Hallett MPH
Clinical Pharmacology of Tobacco Alkaloids 2006 (Cycle XV) $508,848
University of California, San Francisco Peyton Jacob Ph.D.
Clinical pharmacology of tobacco alkaloids 2001 (Cycle X) $373,408
University of California, San Francisco Peyton Jacob Ph.D.
Clinical Pharmacology of Tobacco Alkaloids 1995 (Cycle IV) $393,855
University of California, San Francisco Peyton Jacob Ph.D.
Clinical pharmacology of tobacco alkaloids 1998 (Cycle VII) $439,882
University of California, San Francisco Peyton Jacob Ph.D.
Cloning & Expression of the Apo-B mRNA Editing Factor 1994 (Cycle III) $254,743
J. David Gladstone Institutes Thomas Innerarity Ph.D.
Cloning of a Lung Tumor Transport Gene for Drug Development 1995 (Cycle IV) $104,966
University of California, San Diego Michael Kelner M.D., M.S.
Cognitive effects of gestational nicotine 2004 (Cycle XIII) $60,000
University of California, Irvine Shahrdad Lotfipour Ph.D.
Community and Family Context of Teen Smoking 2008 (Cycle XVII) $270,000
University of California, Los Angeles Ritesh Mistry Ph.D. M.P.A.
Comprehensive evaluation of the ischemic leg 2000 (Cycle IX) $672,390
Stanford University Dwight Nishimura Ph.D.
Comprehensive Tobacco Policy Model 1997 (Cycle VI) $439,963
University of California, Irvine Tammy Tengs Sc.D.
Computer Simulation as a Tool for Reducing SHS Exposure 2007 (Cycle XVI) $118,418
Education Training and Research Associates, Inc. Neil Klepeis
Conformationally constrained nicotine vaccines 2005 (Cycle XIV) $778,921
Scripps Research Institute Kim Janda Ph.D.
Context & consequenes of smoking in a blue-collar cohort 2005 (Cycle XIV) $426,555
Pacific Institute for Research and Evaluation Carol Cunradi Ph.D., M.P.H.
Contributions of CNRs to nicotinic signaling 2001 (Cycle X) $70,000
University of California, San Diego Martina Blank Ph.D.
Control of Mucociliary Clearance in the Respiratory Tract 1995 (Cycle IV) $276,780
University of California, Los Angeles Ellen Dirksen Ph.D.
Controlled study of withdrawal symptoms in teen smokers 2003 (Cycle XII) $499,890
Stanford University Joel Killen Ph.D.
COPD: oxygen transport and metabolism in skeletal muscle 2001 (Cycle X) $224,500
University of California, San Diego Luke Haseler Ph.D.
Co-regulator mechanisms in lung cancer 1999 (Cycle VIII) $38,267
University of California, San Diego Bogi Andersen M.D.
Corporate strategies: design, conduct, publication of resrch 2004 (Cycle XIII) $407,567
University of California, San Francisco Lisa Bero Ph.D.
Correlates of cigarette craving in acute nicotine withdrawal 2003 (Cycle XII) $17,000
University of California, Los Angeles Murray Jarvik M.D., Ph.D.
Correlates of cigarette craving in acute nicotine withdrawal 2003 (Cycle XII) $517,818
Brentwood Biomedical Research Institute Richard Olmstead Ph.D.
Cotinine Metabolism in Infants and Children 2006 (Cycle XV) $509,473
University of California, San Francisco Neal Benowitz M.D.
COX-2 regulation of vaccination responses in lung cancer 2004 (Cycle XIII) $379,362
University of California, Los Angeles Steven Dubinett M.D.
COX-2-dependent modulation of survivin in lung cancer 2003 (Cycle XII) $69,500
University of California, Los Angeles Kostyantyn Krysan Ph.D.
CSF biomarkers of brain metastases from lung cancer 2003 (Cycle XII) $100,000
University of California, San Francisco James Rubenstein M.D., Ph.D.
CT imaging to assist diagnosis of solitary pulmonary nodules 2000 (Cycle IX) $59,002
University of California, Los Angeles Michael McNitt-Gray Ph.D.
Culture and Tobacco Among American Indian Adolescents 2006 (Cycle XV) $827,725
University of Southern California Jennifer Unger Ph.D.
Current legal issues in tobacco 1997 (Cycle VI) $34,746
University of California, San Francisco Brion Fox S.M., J.D.
Curriculum for treating nicotine dependence in psychiatry 2004 (Cycle XIII) $269,243
University of California, San Francisco Judith Prochaska Ph.D., M.P.H.
Cytokine gene-modified dendritic cells for lung cancer 2000 (Cycle IX) $590,523
University of California, Los Angeles Steven Dubinett M.D.
Defining mutagenesis pathways in tobacco-related cancer 2005 (Cycle XIV) $58,993
Scripps Research Institute Bryan O'Neill BA Chemistry
Deposition of inhaled carcinogens in ETS 2001 (Cycle X) $210,446
University of California, Irvine Michael Oldham M.S.
Depression as a predictor of smoking treatment outcome 2001 (Cycle X) $52,467
University of California, San Francisco G. Scott Acton Ph.D.
Detection of occult metastases in patients with lung cancer 1999 (Cycle VIII) $723,842
University of Southern California Richard Cote M.D.
Determinants of smoking among gay & lesbian youth 2000 (Cycle IX) $509,771
University of California, San Francisco Jay Paul Ph.D.
Determinants of Smoking Prevalence among Cambodian Americans 2007 (Cycle XVI) $693,630
California State University, Long Beach Foundation Kimthai Kuoch
Determinants of Smoking Prevalence among Cambodian Americans 2007 (Cycle XVI) $693,630
California State University, Long Beach Foundation Robert Friis Ph.D.
Determinants of Susceptibility to Oxidized Lipoproteins 1995 (Cycle IV) $495,384
University of California, Los Angeles Alan Fogelman M.D.
Determining how cholesterol-rich Lp(a) causes heart disease 1998 (Cycle VII) $797,092
J. David Gladstone Institutes Robert Pitas Ph.D.
Developing new vaccines for lung cancer 1998 (Cycle VII) $398,511
University of California, Los Angeles Michael Roth M.D.
Developing policy to reverse cigar trend: roles of media 1997 (Cycle VI) $249,785
University of California, San Francisco Lisa Bero Ph.D.
Developing treatments that lower blood cholesterol levels 1997 (Cycle VI) $746,536
Scripps Research Institute Linda Curtiss Ph.D.
Development of a blood test for pancreatic cancer 1997 (Cycle VI) $308,819
Stanford University Anson Lowe M.D.
Development of a new device to measure ambulatory smoking 2000 (Cycle IX) $72,238
University of California, Los Angeles Richard Olmstead Ph.D.
Development of Fluorescent Probes for Sensing DNA Mismatches 2006 (Cycle XV) $65,369
California Institute of Technology Mi Hee Lim Ph.D.
Development of nicotine withdrawal measures 2005 (Cycle XIV) $50,956
University of California, San Diego Svetlana Semenova Ph.D.
Development of nicotine withdrawal measures 2005 (Cycle XIV) $91,173
Scripps Research Institute Svetlana Semenova Ph.D.
Developmental Relationship between NK and T-Cell Lineages 1995 (Cycle IV) $434,126
California Institute of Technology Ellen Rothenberg Ph.D.
Diabetes & tobacco exposure in So CA American Indians 2005 (Cycle XIV) $468,390
University of California, San Diego Deborah Morton Ph.D.
Diagnostic tools of HDL damage by tobacco smoke 2000 (Cycle IX) $113,878
Lawrence Berkeley National Laboratory John Bielicki Ph.D.
Diaphragm adaptations following treatment for emphysema 1997 (Cycle VI) $469,400
Cedars-Sinai Medical Center Michael Lewis M.D.
Dietary fat and ETS effects on lung epithelial biology 2003 (Cycle XII) $99,827
University of California, Davis Laura Van Winkle Ph.D.
Discovery of serum markers of lung cancer 1998 (Cycle VII) $120,300
Cedars-Sinai Medical Center Phillip Koeffler M.D.
Disproportionate cost of smoking for communities of color 2004 (Cycle XIII) $278,980
University of California, San Francisco Wendy Max Ph.D.
Dissecting signaling pathways to test cancer-killing agents 1998 (Cycle VII) $69,694
University of California, San Diego Yi Chen Ph.D.
Dissemination of a smoking cessation program for in patients 1999 (Cycle VIII) $710,621
Stanford University C. Barr Taylor M.D.
Dissemination of the Rx for Change in Psychiatry Curriculum 2008 (Cycle XVII) $439,283
University of California, San Francisco Judith Prochaska Ph.D., M.P.H.
Dissuading at-risk youth from smoking via mass media 2000 (Cycle IX) $610,340
University of California, Irvine Cornelia Pechmann Ph.D.
DNA replication, regulation of the cell cycle, and cancer 2000 (Cycle IX) $571,742
California Institute of Technology Judith Campbell Ph.D.
Do receptors mediate the effects of nicotine on anxiety? 2005 (Cycle XIV) $291,060
Salk Institute for Biological Studies Tammy Booker Ph.D.
Does nicotine alter intercellular communication pathways? 1997 (Cycle VI) $68,864
University of California, San Diego Ching-Yi Chen Ph.D.
Does nicotine exposure inhibit convective drug delivery ? 2007 (Cycle XVI) $189,400
La Jolla Bioengineering Institute Ugur Ozerdem M.D.
Does nicotine increase sprouting of pericyte tubes? 2004 (Cycle XIII) $207,300
La Jolla Institute for Molecular Medicine Ugur Ozerdem M.D.
Does nicotine inhibit anticancer activities of Vitamin A? 1997 (Cycle VI) $788,808
The Burnham Institute for Medical Research Xiao-Kun Zhang Ph.D.
Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma 1994 (Cycle III) $389,719
University of California, San Francisco Rik Derynck Ph.D.
Does tobacco exposure delay conception? 2003 (Cycle XII) $447,845
Sequoia Foundation Michelle Pearl Ph.D.
Dynamics of state tobacco control making 1999 (Cycle VIII) $70,000
University of California, San Francisco Michael Givel Ph.D.
Dysregulation of VSMC signaling induced by nicotine 2001 (Cycle X) $683,510
Stanford University Philip Tsao Ph.D.
Early detection of oral cancer 1998 (Cycle VII) $74,901
University of California, Irvine Petra Wilder-Smith D.D.S., Ph.D.
Economic Analysis of Smoking Cessation Therapies 1999 (Cycle VIII) $270,206
University of California, San Francisco James Milton Lightwood Ph.D.
Economic Effects of California Cigarette Tax 1998 (Cycle VII) $98,528
University of California, Berkeley Teh-Wei Hu Ph.D.
Economic Impact of Secondhand Smoke for Communities of Color 2007 (Cycle XVI) $216,038
University of California, San Francisco Wendy Max Ph.D.
Effect of cigarette smoke and nicotine on taste processing 2002 (Cycle XI) $70,000
University of California, Davis Christopher Simons Ph.D.
Effect of cigarette smoking on pulmonary metastasis 2001 (Cycle X) $36,236
University of California, Davis Susan Murin M.D.
Effect of estrogen on ETS-induced glyco-oxidation 2000 (Cycle IX) $24,692
University of California, Davis Jeana LeAnn Benton B.S.
Effect of maternal smoking on early human development 2003 (Cycle XII) $505,975
University of California, San Francisco Susan Fisher Ph.D.
Effect of Maternal Smoking on Early Human Development 2006 (Cycle XV) $489,025
University of California, San Francisco Susan Fisher Ph.D.
Effect of maternal smoking on human placental development 1997 (Cycle VI) $450,000
University of California, San Francisco Susan Fisher Ph.D.
Effect of maternal smoking on human placental development 2000 (Cycle IX) $515,124
University of California, San Francisco Susan Fisher Ph.D.
Effect of nicotine on bone marrow cells 2001 (Cycle X) $520,381
La Jolla Institute for Molecular Medicine Sophia Khaldoyanidi M.D., Ph.D.
Effect of nicotine on fetal hemopoietic stem cell migration 2002 (Cycle XI) $152,352
La Jolla Institute for Molecular Medicine Sophia Khaldoyanidi M.D., Ph.D.
Effect of Oxidation on Rate of ApoA-I - HDL Exchange 2007 (Cycle XVI) $75,000
Children's Hospital Oakland Research Institute Giorgio Cavigiolio Ph.D.
Effect of PDGF inhibition on angiogenesis in lung cancer 2005 (Cycle XIV) $74,500
University of California, San Francisco Beverly Falcon Ph.D.
Effect of secondhand smoke on pulmonary t cell recruitment 1999 (Cycle VIII) $69,094
University of California, Davis Lisa Miller Ph.D.
Effect of sidestream smoke on lung injury and repair 1997 (Cycle VI) $214,070
University of California, Davis Laura Van Winkle Ph.D.
Effect of Sidestream Tobacco Smoke on Parkin Null Mice 2006 (Cycle XV) $48,256
University of California, Los Angeles Owen Kelly Ph.D.
Effect of smoke and gender on bronchiolar injury and repair 2002 (Cycle XI) $413,288
University of California, Davis Laura Van Winkle Ph.D.
Effect of smoke and gender on bronchiolar injury and repair 2005 (Cycle XIV) $418,207
University of California, Davis Laura Van Winkle Ph.D.
Effect of Smoking on Success Rate of In Vitro Fertilization 1995 (Cycle IV) $449,805
University of California, San Diego Hillary Klonoff-Cohen Ph.D.
Effect of Tobacco on Rat Lung Alveolar Lining Liquid 1995 (Cycle IV) $643,213
Lawrence Berkeley National Laboratory Jacob Bastacky M.D.
Effect of tobacco related policy change on smoking behavior 1999 (Cycle VIII) $261,672
University of California, San Diego David Burns M.D.
Effect of tobacco smoke on leucocyte adhesion in vivo 2001 (Cycle X) $1,023,946
La Jolla Institute for Molecular Medicine Pragada Sriramarao Ph.D.
Effect of tobacco smoke on leukocyte adhesion in vivo 1998 (Cycle VII) $754,361
La Jolla Institute for Molecular Medicine Pragada Sriramarao Ph.D.
Effect of tobacco smoke on lung airway surface liquid 1998 (Cycle VII) $115,658
Children's Hospital Oakland Research Institute Jacob Bastacky M.D.
Effect of tobacco smoke on nitric oxide synthesis 1999 (Cycle VIII) $70,000
University of California, Davis Patrick Wong Ph.D.
Effect of tobacco toxins on human germ cell development 2006 (Cycle XV) $33,290
University of California, San Francisco Kehkooi Kee Ph.D.
Effect of tobacco toxins on human germ cell development 2006 (Cycle XV) $41,710
Stanford University Kehkooi Kee Ph.D.
Effect of tobacco-related policy change on smoking behavior 2002 (Cycle XI) $303,504
University of California, San Diego David Burns M.D.
Effective diffusion of evidence-based tobacco curricula 2002 (Cycle XI) $47,747
University of Southern California Silvana Skara MPH
Effectiveness Evaluation of the I Decide Program 2006 (Cycle XV) $162,304
University of Southern California Louise Rohrbach Ph.D., M.P.H.
Effectiveness of a large prenatal tobacco reduction program 2004 (Cycle XIII) $425,181
Sequoia Foundation Michelle Pearl Ph.D.
Effectiveness of two different regimens in smoking clinic 1999 (Cycle VIII) $272,989
University of California, Los Angeles Scott Eliot Sherman M.D., M.P.H.
Effects of Disturbed Flow on Endothelial Cell Function 1995 (Cycle IV) $52,345
University of California, Los Angeles Henry Honda M.D.
Effects of Environmental Tobacco Smoke on Pulmonary Allergy 1995 (Cycle IV) $256,805
University of California, Davis Laurel Gershwin D.V.M., Ph.D.
Effects of environmental tobacco smoke on pulmonary allergy 1998 (Cycle VII) $282,568
University of California, Davis Laurel Gershwin D.V.M., Ph.D.
Effects of environmental tobacco smoke on the artery wall 1998 (Cycle VII) $449,673
University of California, Davis John Rutledge M.D.
Effects of exposure to secondhand smoke 1999 (Cycle VIII) $194,404
Kaiser Foundation Research Institute Carlos Iribarren M.D., Ph.D., M.P.H.
Effects of Legislation on ETS Exposure in California 1997 (Cycle VI) $245,189
University of California, San Diego Arthur Farkas Ph.D.
Effects of nicotine exposure in utero on brain cell death 1997 (Cycle VI) $74,499
University of California, San Diego Jerold Chun M.D., Ph.D.
Effects of Nicotine on Brain Development 1999 (Cycle VIII) $55,404
Cedars-Sinai Medical Center Christine Cloak
Effects of nicotine on fetal hematopoiesis 2007 (Cycle XVI) $764,400
Torrey Pines Institute for Molecular Studies Sophia Khaldoyanidi M.D., Ph.D.
Effects of nicotine on hematopoietic stem cell migration 2005 (Cycle XIV) $74,500
La Jolla Institute for Molecular Medicine Naira Serobyan M.D.
Effects of nicotine on postinfarction cardiac remodeling 1998 (Cycle VII) $459,799
University of California, San Diego Francisco Villarreal M.D., Ph.D.
Effects of nicotine on schizophrenia-like cognitive deficits 2006 (Cycle XV) $60,000
University of California, San Diego Nurith Amitai B.S.
Effects of nicotine on taste processing 2001 (Cycle X) $24,834
University of California, Davis Christopher Simons Ph.D.
Effects of nicotine withdrawal on aviator performance 2001 (Cycle X) $515,243
Stanford University Jerome Yesavage M.D.
Effects of Outlet/Ad Density on Teen Smking and Brand Choice 2005 (Cycle XIV) $410,979
Stanford University Lisa Henriksen Ph.D.
Effects of passive smoking and pregnancy 1999 (Cycle VIII) $565,186
Lawrence Livermore National Laboratory Kenneth Turteltaub Ph.D.
Effects of perinatal nicotine on the Brain 1997 (Cycle VI) $93,122
LA Biomedical Research Institute at Harbor-UCLA Medical Center Russell Poland Ph.D.
Effects of prenatal nicotine exposure on nicotinic receptors 2000 (Cycle IX) $471,654
University of California, San Francisco Peter Sargent Ph.D.
Effects of pro and anti-smoking cues in stores on craving 2004 (Cycle XIII) $373,894
Stanford University Lisa Henriksen Ph.D.
Effects of PSA content and formal features on smoking norms 1999 (Cycle VIII) $44,284
Stanford University Michael Antecol Ph.D.
Effects of Selegiline on craving for nicotine 1998 (Cycle VII) $100,450
Stanford University Joel Killen Ph.D.
Effects of side stream tobacco smoke on DNA deletions 2005 (Cycle XIV) $58,876
University of California, Los Angeles Mitsuko Yamamoto B.S.
Effects of social capital on smoking: elasticity & pathways 2005 (Cycle XIV) $98,854
University of California, Berkeley Richard Scheffler Ph.D.
Effects of tobacco on inflammatory cell responses 1997 (Cycle VI) $223,585
University of California, Davis Lisa Miller Ph.D.
Effects of tobacco smoke exposure on hormones and fertility 1998 (Cycle VII) $115,335
Sequoia Foundation Gayle Windham Ph.D.
Effects of tobacco smoke on airway bactericidal activity 2001 (Cycle X) $87,079
University of California, Davis Yuan-Pu Di Ph.D.
Effects of Tobacco Smoke on Mucin Production in Rat Airways 1995 (Cycle IV) $356,400
University of California, San Francisco Carol Basbaum Ph.D.
Effects of Tobacco Taxation Upon Population Health Status 1997 (Cycle VI) $206,547
University of California, San Diego Robert Kaplan Ph.D.
Effects of tobacco-induced gamete damage on embryogenesis 2004 (Cycle XIII) $158,853
Lawrence Livermore National Laboratory Francesco Marchetti Ph.D.
Effects of tobacco-induced gamete damage on embryogenesis 2004 (Cycle XIII) $608,740
Lawrence Berkeley National Laboratory Francesco Marchetti Ph.D.
Efficacy of the nicotine patch in adolescents & young adults 2002 (Cycle XI) $69,800
University of California, San Francisco Mark Rubinstein M.D.
Electrophysiological Effects of Perinatal Nicotine Exposure 1995 (Cycle IV) $446,225
Scripps Research Institute Cindy Ehlers Ph.D.
Electrophysiological Effects of Perinatal Nicotine Exposure 1995 (Cycle IV) $293,752
San Diego State University Research Foundation Edward Riley Ph.D.
Emotional intelligence and smoking across ethnicity 2000 (Cycle IX) $52,392
University of Southern California Dennis Trinidad Ph.D., M.P.H.
Engineering Salmonella for lung cancer therapy 2007 (Cycle XVI) $291,600
Sidney Kimmel Cancer Center Nabil Arrach Ph.D.
Environmental contexts of smoking for Southeast Asians 2004 (Cycle XIII) $728,324
Pacific Institute for Research and Evaluation Juliet Lee BA, MA, PhD
Environmental influences on tobacco use amg AAPI communities 2004 (Cycle XIII) $204,722
Asian Pacific Partners for Empowerment Advocacy & Leadership Rod Lew MPH
Environmental influences on tobacco use amg AAPI communities 2004 (Cycle XIII) $311,543
Assoc of Asian Pacific Community Health Organizations Rod Lew MPH
Environmental influences on tobacco use amg AAPI communities 2004 (Cycle XIII) $149,610
CSU Fullerton Auxiliary Services Corporation Sora Park Tanjasiri DrPH, MPH
Environmental tobacco smoke and early atherosclerosis 1997 (Cycle VI) $383,814
University of Southern California Wendy Mack Ph.D.
Environmental tobacco smoke and newborn lung development 1997 (Cycle VI) $440,500
University of California, Davis Kent Pinkerton Ph.D.
Environmental tobacco smoke effects on lung surfactant 1999 (Cycle VIII) $423,216
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
Environmental tobacco smoke effects on lung surfactant 2002 (Cycle XI) $406,444
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
Environmental tobacco smoke effects on lung surfactant 1999 (Cycle VIII) $47,656
University of California, Santa Barbara Junqi Ding
Environmental tobacco smoke exposure & adult asthma 2001 (Cycle X) $460,032
University of California, San Francisco Mark Eisner M.D., M.P.H.
Enzymatic targets for anticancer therapy 2002 (Cycle XI) $267,304
J. David Gladstone Institutes Martin Bergo M.D., Ph.D.
Epigenetic Regulation of Airway MUC gene expression by smoke 2007 (Cycle XVI) $420,000
University of California, Davis Reen Wu Ph.D.
Ethnic and gender variation in nicotine detoxification 2003 (Cycle XII) $424,142
SRI International Huijun Ring Ph.D.
Ethnic difference in cigarette smoking dynamics among youth 1999 (Cycle VIII) $366,852
University of Southern California Xinguang Chen Ph.D.
Ethnicity and school-level effect on CA student tobacco use 2004 (Cycle XIII) $422,120
University of California, Los Angeles William McCarthy Ph.D.
ETS Effects on airway development in the primate lung 1998 (Cycle VII) $483,652
University of California, Davis Kent Pinkerton Ph.D.
ETS effects on breathing patterns 2000 (Cycle IX) $590,780
University of California, Davis Jesse Joad M.D.
ETS Effects on Lung Surfactant 2005 (Cycle XIV) $419,000
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
ETS effects on pulmonary breathing patterns 1997 (Cycle VI) $446,954
University of California, Davis Jesse Joad M.D.
ETS exposures in the California Teachers Study cohort 1998 (Cycle VII) $449,677
Public Health Institute Peggy Reynolds Ph.D.
Evaluating Mechanisms of Change in a Smoking Intervention 2008 (Cycle XVII) $202,500
RAND Corporation Harold Green Ph.D.
Evaluation of ad strategies for preventing youth tobacco use 1997 (Cycle VI) $136,953
University of California, Irvine Cornelia Pechmann Ph.D.
Evaluation of office ETS exposure in relation to AB 13 1999 (Cycle VIII) $242,063
Public Health Institute Leon Alevantis M.S.
Evaluation of office ETS exposure in relation to AB13 1999 (Cycle VIII) $208,554
Lawrence Berkeley National Laboratory William Fisk B.S., M.S.
Experimental evaluation of minors' access to tobacco 2000 (Cycle IX) $655,347
San Diego State University Research Foundation Hope Landrine Ph.D.
Explaining racial differences in smoking 1999 (Cycle VIII) $151,430
San Diego State University Research Foundation Hope Landrine Ph.D.
Explaining racial differences in smoking 1999 (Cycle VIII) $149,280
Public Health Foundation Enterprises, Inc. Hope Landrine Ph.D.
Exploration of tobacco use in Asian Pacific Islander youth 2002 (Cycle XI) $92,076
Assoc of Asian Pacific Community Health Organizations Sora Park Tanjasiri DrPH, MPH
Exploration of tobacco use in Asian Pacific Islander youth 2002 (Cycle XI) $92,076
Assoc of Asian Pacific Community Health Organizations Rod Lew MPH
Exploring tobacco cessation services on CA college campuses 2001 (Cycle X) $81,995
Public Health Institute Dianne Barker M.H.S.
Exploring transdisciplinary scientific collaboration 2001 (Cycle X) $29,040
University of California, Irvine Juliana Lynn Fuqua Ph.D.
Expos children to secondhand smoke through cntaminated homes 2004 (Cycle XIII) $754,504
San Diego State University Research Foundation Georg Matt Ph.D.
Exposure to Secondhand Smoke: Effects of Proximity 2007 (Cycle XVI) $672,582
Stanford University Lynn Hildemann Ph.D.
Expressing & Cloning of ATP-Sensitive Potassium Channels 1995 (Cycle IV) $286,163
University of California, Santa Barbara Carol Vandenberg Ph.D.
Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle IV) $211,090
J. David Gladstone Institutes Beatriz Levy-Wilson Ph.D.
Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle IV) $569,759
Palo Alto Medical Foundation Research Institute Beatriz Levy-Wilson Ph.D.
Family factors in smoking acquisition among Latino youth 1998 (Cycle VII) $865,636
San Diego State University Research Foundation Rafael Laniado-Laborin M.D., MPH
Fertility smoking and early mammalian development 2004 (Cycle XIII) $392,451
University of California, Riverside Prudence Talbot Ph.D.
Fertility, smoking and early mammalian development 1997 (Cycle VI) $452,243
University of California, Riverside Prudence Talbot Ph.D.
Fertility, smoking and early mammalian development 2001 (Cycle X) $454,490
University of California, Riverside Prudence Talbot Ph.D.
Fertility, Smoking, and Early Mammalian Development 1995 (Cycle IV) $321,193
University of California, Riverside Prudence Talbot Ph.D.
Focal adhesion kinase regulation of Cox-2 in lung cancer 2003 (Cycle XII) $74,520
Scripps Research Institute Satyajit Mitra Ph.D.
Function and Regulation of the Retinoblastoma Protein 1995 (Cycle IV) $385,031
University of California, San Diego James Feramisco Ph.D.
Functional Antagonists of Nicotine 1995 (Cycle IV) $236,936
Northern California Institute for Research & Education S. Paul Berger M.D.
Functional MRI of neural activation 1997 (Cycle VI) $48,447
University of California, Los Angeles Shantanu Sinha Ph.D.
Functional significance of the protein CD40 in lung cancer 1998 (Cycle VII) $35,000
University of California, San Diego Kenneth Grudko M.D.
Functions of IRF-1 and Smad3 interaction in lung cancer 2001 (Cycle X) $69,750
University of California, San Francisco Pierre Lee Ph.D.
Fusion proteins that convert VEGF into a cell death factor 2007 (Cycle XVI) $100,000
University of California, San Francisco Timothy Quinn M.D.
Gastroschisis: maternal smoking and genetic variation 2007 (Cycle XVI) $673,269
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Gene Augmentation Therapy for Tobacco Induced Emphysema 1995 (Cycle IV) $224,786
University of California, Davis Robert Malone M.D.
Gene Markers for Hypertension 1995 (Cycle IV) $356,151
University of California, San Francisco Theodore Kurtz M.D.
Gene therapy for emphysema 1997 (Cycle VI) $443,179
University of California, San Francisco Francis Szoka Ph.D.
Genes affecting nicotine response in C. elegans 2006 (Cycle XV) $100,000
University of California, San Diego William Schafer Ph.D.
Genetic links to nicotine addiction: ethics of testing teens 1999 (Cycle VIII) $115,591
Stanford University Thomas Raffin M.D.
Genetic Susceptibility to Lung Cancer 1995 (Cycle IV) $104,580
LA Biomedical Research Institute at Harbor-UCLA Medical Center Henry Lin M.D.
Genetic susceptibility to tobacco-induced lung cancer 1998 (Cycle VII) $406,120
University of California, Los Angeles Oliver Hankinson Ph.D.
Genetics and Impulsivity in Smoking Initiation 2008 (Cycle XVII) $283,612
Veterans Medical Research Foundation Neal Doran Ph.D.
Genomic Assay to Identify Targets of Anticancer Therapeutics 2008 (Cycle XVII) $75,000
Stanford University Nolan Ko Ph.D.
Genomics & transcriptome of oral precncr prgrssion in smkers 2004 (Cycle XIII) $189,541
University of California, Los Angeles Xiaofeng Zhou Ph.D.
Geography of underage tobacco retail sales in Los Angeles 2003 (Cycle XII) $622,260
Pacific Institute for Research and Evaluation Robert Lipton BA, MA, MPH, Ph.D.
Global determinants of tobacco use onset in diverse youth 1998 (Cycle VII) $280,749
Education Training and Research Associates, Inc. Scott Carvajal Ph.D., MPH
Grainyhead-Like Transcription factor in Airway Epithelium 2008 (Cycle XVII) $60,000
University of California, Irvine Ambica Bhandari Masters in Biotechnology
Heat shock proteins as biomarkers of lung oxidant stress 2000 (Cycle IX) $24,338
University of California, Davis Kurt Williams D.V.M.
Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke 1995 (Cycle IV) $454,365
Lawrence Berkeley National Laboratory Rolf Mehlhorn Ph.D.
Heparan sulfate small molecules for contro tumor cell growth 2005 (Cycle XIV) $626,807
California Institute of Technology Linda Hsieh-Wilson Ph.D.
-Heterologous Expression of Brain Nicotinic Acetylcholine Re 1995 (Cycle IV) $598,774
California Institute of Technology Henry Lester Ph.D.
High Resolution OCT for Early Airway Cancer Detection 2007 (Cycle XVI) $480,636
University of California, Irvine Matthew Brenner M.D.
Hmong cultural practices and patterns of tobacco use 1999 (Cycle VIII) $83,383
California Health Collaborative Vickie Krenz Ph.D., M.S.P.H.
Hmong smoking prevalence & tobacco uses 2001 (Cycle X) $539,350
California State University, Fresno Foundation Vickie Krenz Ph.D., M.S.P.H.
Hmong smoking prevalence & tobacco uses 2001 (Cycle X) $539,350
California State University, Fresno Foundation Pao Fang
Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle VII) $385,808
Scripps Research Institute Carole Banka Ph.D.
Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle VII) $245,584
La Jolla Institute for Molecular Medicine Carole Banka Ph.D.
Hormones and Tobacco: Joint Effects on Reproduction 1994 (Cycle III) $263,611
Public Health Institute Shanna Swan Ph.D.
How are beneficial cholesterol transport proteins produced? 1998 (Cycle VII) $37,069
J. David Gladstone Institutes Martin Hersberger Ph.D.
How do nic and cig smoke affect neural control of breathing? 2004 (Cycle XIII) $392,620
University of California, Los Angeles Xuesi Shao M.D.
How do tobacco smoke compounds impair lung surfactant? 1997 (Cycle VI) $74,961
University of California, Santa Barbara Joseph Zasadzinski Ph.D.
How does cardiac fuel metabolism influence heart disease? 1998 (Cycle VII) $262,005
J. David Gladstone Institutes Murielle Marie Veniant Ph.D.
How does cigarette smoke induce cancer? 1997 (Cycle VI) $811,518
Beckman Research Institute of the City of Hope Gerd Pfeifer Ph.D.
How does smoke activate mucin transcription in lung cells? 1998 (Cycle VII) $432,415
University of California, San Francisco Carol Basbaum Ph.D.
How omega-3 fatty acids prevent or slow cancer 2006 (Cycle XV) $74,808
The Burnham Institute for Medical Research Hu Zhou Ph.D.
How smoke induces lung damage via oxidative stress 2006 (Cycle XV) $75,000
University of California, Davis Michal Levy Ph.D.
Human neurophysiology of nicotine analgesia: sex differences 2000 (Cycle IX) $595,994
University of California, San Francisco David Becker Ph.D.
Human oocyte development and PAH exposure 2005 (Cycle XIV) $260,944
University of California, San Francisco Renee Reijo Pera Ph.D.
Human oocyte development and PAH exposure 2005 (Cycle XIV) $158,556
Stanford University Renee Reijo Pera Ph.D.
Human tryptase gene expression: role in COPD 2000 (Cycle IX) $545,409
University of California, San Francisco George Caughey M.D.
Hyperactive nicotine receptors 1997 (Cycle VI) $486,158
California Institute of Technology Henry Lester Ph.D.
Hyperactive nicotine receptors 2000 (Cycle IX) $1,138,225
California Institute of Technology Henry Lester Ph.D.
Hyperactive nicotine receptors 2003 (Cycle XII) $675,487
California Institute of Technology Henry Lester Ph.D.
Hypnosis for Smoking Relapse Prevention 2007 (Cycle XVI) $509,353
University of California, San Francisco Timothy Carmody Ph.D.
IAP Antagonists for lung cancer treatment 2004 (Cycle XIII) $727,658
The Burnham Institute for Medical Research John Reed M.D., Ph.D.
Identification on Tumors of Molecular Targets for NK Cells 1995 (Cycle IV) $314,006
University of California, San Francisco William Seaman M.D.
IL-12 genetic immunotherapy for lung cancer 1999 (Cycle VIII) $75,000
University of California, Los Angeles Steven Dubinett M.D.
Immune Targeted Therapy for Lung Cancer 2006 (Cycle XV) $419,500
University of California, Los Angeles Sherven Sharma Ph.D.
Immunopharmacotherapy as a treatment for nicotine addiction 2002 (Cycle XI) $515,270
Scripps Research Institute Kim Janda Ph.D.
Impact of Cultural Competence on Treatment Outcomes 2002 (Cycle XI) $1,500
University of California, Davis Nolan Zane Ph.D.
Impact of MPO in Tobacco-related Cardiovascular Disease 2007 (Cycle XVI) $818,160
Sidney Kimmel Cancer Center Wanda Reynolds Ph.D.
Impact of nicotinic signaling on neuronal gene expression 2000 (Cycle IX) $30,055
University of California, San Diego Karen Chang B.A.
Impact of Positive Mood on Self-Control Depletion in Smoking 2007 (Cycle XVI) $75,000
University of California, San Francisco Dikla Shmueli Ph.D.
Implementation of California AB 13: smoking ban in bars 1998 (Cycle VII) $315,181
University of California, San Francisco Lisa Bero Ph.D.
Implementation of tobacco prevention programming and smoking 2003 (Cycle XII) $58,557
University of Southern California Pamela Elfenbaum MPH
Implementation of tobacco programs in Calif schools 2000 (Cycle IX) $765,192
University of Southern California Louise Rohrbach Ph.D., M.P.H.
Importance of Rce1 and Ras in tobacco-induced cancers 1999 (Cycle VIII) $75,209
J. David Gladstone Institutes Martin Bergo M.D., Ph.D.
Improved chemoradiotherapy of lung cancer 2005 (Cycle XIV) $661,920
California Pacific Medical Center Research Institute Li-Xi Yang M.D., Ph.D.
Improved therapy of lung cancer 2000 (Cycle IX) $668,814
California Pacific Medical Center Research Institute Li-Xi Yang M.D., Ph.D.
Improving tobacco use assessment among youth via telephone 1997 (Cycle VI) $347,440
University of California, Berkeley Joel Moskowitz Ph.D.
Individual and gender differences in nicotine sensitivity 2003 (Cycle XII) $69,495
University of California, Irvine Minjung Park Ph.D.
Indoor measurements of environmental tobacco smoke 1997 (Cycle VI) $634,217
Lawrence Berkeley National Laboratory Richard Sextro Ph.D.
Inflammation, innate immunity, TLRs, and atherosclerosis 2002 (Cycle XI) $697,650
Scripps Research Institute Peter Tobias Ph.D.
Inflammatory compounds:role in tobacco-related lung disease 1998 (Cycle VII) $447,367
University of California, San Diego Timothy Bigby M.D.
Influences that promote ethnic disparities in smoking 2003 (Cycle XII) $269,971
University of California, San Diego Dennis Trinidad Ph.D., M.P.H.
Inheritance and Smoking in Urinary Tract & Pancreas Cancer 1995 (Cycle IV) $248,283
University of Southern California Thomas Mack M.D., M.P.H.
Inhibition of cell death in head and neck cancer cells 2005 (Cycle XIV) $24,148
University of Southern California Ram Kumar Subramanyan M.D.
Inhibition of MYC-activated gene expression by polyamides 2007 (Cycle XVI) $75,000
California Institute of Technology Daniel Harki Ph.D.
Innovation to prevent post-partum relapse 2000 (Cycle IX) $75,000
University of California, San Francisco Jennifer Haas M.D.
Instant SHS Feedback as a Catalyst for Smoke-Free Homes 2008 (Cycle XVII) $129,917
San Diego State University Research Foundation Neil Klepeis
Integrin Cytoplasmic Domains and Ligand Affinity Modulation 1994 (Cycle III) $522,649
Scripps Research Institute Timothy O'Toole Ph.D.
Integrin receptors and heart disease 2005 (Cycle XIV) $35,323
University of California, San Diego Anthony Partridge Ph.D.
Integrins and drug resistance in small cell lung cancer 2003 (Cycle XII) $780,144
The Burnham Institute for Medical Research Kristiina Vuori M.D., Ph.D.
Interaction of LDL receptor family members with ligands 2008 (Cycle XVII) $291,600
Children's Hospital Oakland Research Institute Taichi Yamamoto Ph.D.
Interactions of Moesin during platelet activation 1995 (Cycle IV) $428,524
Stanford University Heinz Furthmayr M.D.
Interdependence - smoking behavior & mood in natural setting 1997 (Cycle VI) $222,843
University of California, Los Angeles Richard Olmstead Ph.D.
Internet health research center: smoking, Latinos, & the Web 2004 (Cycle XIII) $535,096
University of California, San Francisco Ricardo Munoz Ph.D.
Internet-enhanced proactive telephone counseling 2002 (Cycle XI) $674,731
Veterans Medical Research Foundation Leslie Lenert M.D., M.S.
Investigating College Student Cigarette Smoking Self-change 2007 (Cycle XVI) $138,596
Veterans Medical Research Foundation Mark Myers Ph.D.
Involvement of PI3K pathway in bladder cancer invasion 2002 (Cycle XI) $224,984
University of California, Davis Colleen Sweeney Ph.D.
IRAK-1 & active TGF-beta: Counter-regulators in emphysema? 2003 (Cycle XII) $69,000
University of California, San Francisco George Su M.D.
Irritant & Analgesic Effects of Nicotine 1995 (Cycle IV) $75,000
University of California, Davis Earl Carstens Ph.D.
Irritant and analgesic effects of nicotine 2002 (Cycle XI) $226,650
University of California, Davis Earl Carstens Ph.D.
Irritant and pain-reducing effects of nicotine 1997 (Cycle VI) $415,704
University of California, Davis Earl Carstens Ph.D.
Isolation of a Tumor Promoter Induced C-Fos Kinase 1995 (Cycle IV) $55,000
University of California, San Diego Tuula Kallunki Ph.D.
Isolation of lung tumor proteins for a novel treatment 1998 (Cycle VII) $75,000
University of California, San Diego Michael Kelner M.D., M.S.
Isothiocyantes among African Americans and Caucasions 2002 (Cycle XI) $73,270
University of California, Irvine Catherine Carpenter M.P.H., Ph.D.
Keep me smokefree 1998 (Cycle VII) $550,002
Education Training and Research Associates, Inc. Carol D'Onofrio DrPH
Latino and Asian American college students' smoking 2003 (Cycle XII) $59,500
University of California, Riverside Michiko Otsuki Ph.D.
LDL pathophysiology and lipoprotein structure 2003 (Cycle XII) $527,245
Children's Hospital Oakland Research Institute Robert Ryan Ph.D.
Lesbian, gay, bisexual and transgender tobacco use 2004 (Cycle XIII) $302,119
Kaiser Foundation Research Institute Elisabeth Gruskin DrPH
Life histories: Chinese-American elders' smoking encounters 2000 (Cycle IX) $17,146
Stanford University Matthew Kohrman Ph.D.
Lifetime passive smoke exposure and breast cancer in the CTS 2004 (Cycle XIII) $285,300
Northern California Cancer Center Peggy Reynolds Ph.D.
Lifetime passive smoke exposure and breast cancer in the CTS 2004 (Cycle XIII) $122,659
Public Health Institute Peggy Reynolds Ph.D.
Lipoprotein classes and susceptibility to atherosclerosis 1998 (Cycle VII) $702,940
J. David Gladstone Institutes Stephen Young M.D.
Liposome targeted chemotherapy to treat lung cancer 1999 (Cycle VIII) $75,000
University of California, San Francisco Francis Szoka Ph.D.
Long-term adherence after pulmonary rehabilitation for COPD 2001 (Cycle X) $56,118
University of California, San Diego Pia Santiago B.A.
Low-Cost Contingency Management for Smoking Cessation 2008 (Cycle XVII) $478,751
University of California, San Francisco Timothy Carmody Ph.D.
Lowering Smoking & ETS Risks in Immigrant Pacific Rim Youth 1998 (Cycle VII) $1,955,276
University of Southern California C. Anderson Johnson Ph.D.
Lung cancer therapy with in vivo-generated dendritic cells 2001 (Cycle X) $225,000
University of California, Los Angeles Saroj Basak
Lung cancer treatment: The total synthesis of ineleganolide 2005 (Cycle XIV) $59,700
California Institute of Technology Jennifer Roizen B.A.
Lung volume reduction surgery in an animal emphysema model 2000 (Cycle IX) $456,336
University of California, Irvine Matthew Brenner M.D.
Lung volume reduction surgery in an emphysema model 1997 (Cycle VI) $404,139
University of California, Irvine Matthew Brenner M.D.
Macrophage DAP12 pathway in emphysema 2007 (Cycle XVI) $387,237
University of California, San Francisco Laura Koth M.D.
Macrophage function in atherosclerosis 2000 (Cycle IX) $709,200
Scripps Research Institute Linda Curtiss Ph.D.
Macular pigment regeneration upon smoking cessation 1997 (Cycle VI) $74,988
University of California, Berkeley Theodore Cohn Ph.D.
Major Local Tobacco Control Ordinances in the United States 1997 (Cycle VI) $26,244
American Nonsmokers' Rights Foundation Robin Hobart M.P.P., M.P.H.
Mapping of Genetic Loci for Nicotine Dependence 1998 (Cycle VII) $982,095
Ernest Gallo Clinic and Research Center Kirk Wilhelmsen M.D., Ph.D.
Marketing low-tar cigarettes and new harm-reduced products 2005 (Cycle XIV) $74,500
University of California, San Francisco Stacey Anderson Ph.D.
Maternal DNA repair of tobacco-induced sperm lesions 1998 (Cycle VII) $1,046,880
Lawrence Livermore National Laboratory Andrew Wyrobek Ph.D.
Maternal Smoking Habit Modification Via Fetal Visualization 1995 (Cycle IV) $54,471
University of California, San Diego Dolores Pretorius M.D.
MCP-1 and TGFb in pulmonary emphysema 2002 (Cycle XI) $78,241
University of California, San Francisco David Morris M.D.
Measuring adolescent smoking cessation motives and methods 2001 (Cycle X) $103,273
Veterans Medical Research Foundation Mark Myers Ph.D.
Measuring prenatal tobacco exposure in newborn blood spots 2008 (Cycle XVII) $506,927
Sequoia Foundation Juan Yang Ph.D.
Mechanism of apparent long-term nicotinic inactivation 2000 (Cycle IX) $20,565
University of California, Riverside Li Jia M.S.
Mechanism of DNA break repair in germline cells 2007 (Cycle XVI) $75,000
University of California, Davis Amitabh Nimonkar Ph.D.
Mechanism of nicotine action in developing lung 2000 (Cycle IX) $720,281
University of Southern California Carol Wuenschell Ph.D.
Mechanism of smoke-induced MUC5B gene expression 2001 (Cycle X) $392,117
University of California, Davis Reen Wu Ph.D.
Mechanism of stress effects on weight in nicotine withdrawal 1998 (Cycle VII) $407,019
University of California, San Francisco Jon Levine M.D., Ph.D.
Mechanism of TGF-a shedding in lung cancer development 2003 (Cycle XII) $69,600
University of California, San Francisco Yang Xiao Ph.D.
Mechanisms by which tobacco accelerates atherosclerosis 1998 (Cycle VII) $675,731
Stanford University John Cooke M.D., Ph.D.
Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco 1994 (Cycle III) $314,974
Stanford University Gary Gibbons M.D.
Mechanisms of targeted therapy resistance in lung cancer 2006 (Cycle XV) $358,500
University of California, Los Angeles Kostyantyn Krysan Ph.D.
Mechanisms of Tobacco-Induced Retinal Neovascularization 2006 (Cycle XV) $155,550
Stanford University John Cooke M.D., Ph.D.
Mechanisms of Tumor Suppressor in Lung Cancer Initiation 2008 (Cycle XVII) $75,000
University of California, Davis Jie Liu Ph.D.
Mechanisms underlying diaphragm adaptations in emphysema 1998 (Cycle VII) $642,624
Cedars-Sinai Medical Center Mario Fournier Ph.D.
Mechanisms underlying modulations of respiration by nicotine 2001 (Cycle X) $330,458
University of California, Los Angeles Xuesi Shao M.D.
Media and smoking among adolescent girls across ethnicity 1999 (Cycle VIII) $53,987
University of Southern California Dongyun Yang M.D.
Membrane proteins and TGF-alpha/EGFR: a role in lung cancer? 1999 (Cycle VIII) $40,436
University of California, San Francisco Wen Shi Ph.D.
Membrane Signaling Pathways of RAS/RAB Proteins 1995 (Cycle IV) $574,559
Scripps Research Institute William Balch Ph.D.
Mentholated cigarettes and risk of acute MI, CHD, and stroke 2002 (Cycle XI) $106,246
Kaiser Foundation Research Institute Stephen Sidney M.D.
Methyl-DNA Binding Protein Regulation and Function 1999 (Cycle VIII) $54,546
University of California, San Diego Darren Casteel
Micro RNA and dopamine-induced dentritic protein synthesis 2005 (Cycle XIV) $59,000
California Institute of Technology Hwan-Ching Tai B.S.
Mild carbon monoxide exposure impairs the inner ear 2005 (Cycle XIV) $397,320
University of California, Los Angeles Ivan Lopez Ph.D.
Mitotic spindle checkpoint & chromosomal instability 2000 (Cycle IX) $69,500
Ludwig Institute for Cancer Research Zahid Bonday Ph.D.
Mobilized dendritic cells for lung cancer 2000 (Cycle IX) $950,821
Stanford University Edgar Engleman M.D.
Model for surveillance of CA tobacco control policies 2001 (Cycle X) $325,761
Pacific Institute for Research and Evaluation Harold Holder Ph.D.
Modeling cost/effectiveness of tobacco control programs 2002 (Cycle XI) $129,915
University of California, San Diego Robert Kaplan Ph.D.
Modeling cost/effectiveness of tobacco control programs 2002 (Cycle XI) $23,238
University of California, Los Angeles Robert Kaplan Ph.D.
Modeling ETS Exposure and Dose Using PDA E-Diaries 2006 (Cycle XV) $291,531
San Diego State University Research Foundation Marilyn Johnson-Kozlow Ph.D.
Modeling sleep disturbance during nicotine withdrawal 2002 (Cycle XI) $424,344
SRI International Teresa Steininger Ph.D.
Modeling the relation of smoking to the ovarian function 1999 (Cycle VIII) $53,448
University of California, Davis Yan Liu M.D.
Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle XVI) $762,411
Scripps Research Institute Tsung-Hsien Chuang Ph.D.
Molecular Dynamics & Regulation of Apo A-I's Conformation 2007 (Cycle XVI) $644,293
Children's Hospital Oakland Research Institute Michael Oda Ph.D.
Molecular neurobiology of nicotine addiction 2001 (Cycle X) $263,298
University of California, Los Angeles Jim Boulter Ph.D.
Molecular origins of ApoB atherogenic lipoproteins 2000 (Cycle IX) $445,617
University of California, San Francisco Robert Hamilton Ph.D.
Molecular predictors of oral cancer development 2002 (Cycle XI) $419,000
University of California, San Francisco Richard Charles Jordan D.D.S., Ph.D.
Molecular targets for tobacco oxidants in lung cell death 2001 (Cycle X) $70,000
University of California, Davis Tommer Ravid Ph.D.
Monitoring exposure to tobacco-specific nitrosamines 1999 (Cycle VIII) $74,999
University of California, Riverside Thomas Morton Ph.D.
Motivational interviewing to prevent postpartum relapse 1997 (Cycle VI) $282,502
Kaiser Foundation Research Institute Virginia Quinn MPH
Motivation-enhanced teenage tobacco use cessation 1997 (Cycle VI) $750,248
University of Southern California Steve Sussman Ph.D.
Multibehavioral changes for disease prevention among smokers 2002 (Cycle XI) $69,824
University of California, San Francisco Judith Prochaska Ph.D., M.P.H.
Natural history of tobacco addiction in adolescents 1998 (Cycle VII) $499,505
University of California, San Francisco Anna-Barbara Moscicki M.D.
Negative effects of smoke on novel HDL mimetic therapies 2008 (Cycle XVII) $661,125
Lawrence Berkeley National Laboratory John Bielicki Ph.D.
Neural mechanisms underlying nicotine as a 'gateway' drug 2007 (Cycle XVI) $60,000
University of California, Irvine Susan McQuown B.A.
Neuroadaptations underlying nicotine dependence 2002 (Cycle XI) $60,379
Scripps Research Institute Adrie Bruijnzeel Ph.D.
Neurobehavioral consequences of adolescent nicotine exposure 2000 (Cycle IX) $120,000
Scripps Research Institute Cindy Ehlers Ph.D.
Neurobehavioral consequences of adolescent nicotine exposure 2001 (Cycle X) $630,710
Scripps Research Institute Cindy Ehlers Ph.D.
Neurobiological substrates of nicotine addiction 2003 (Cycle XII) $723,613
Scripps Research Institute Athina Markou Ph.D.
Neurobiological substrates of nicotine addiction 2006 (Cycle XV) $419,503
University of California, San Diego Athina Markou Ph.D.
Neurobiological substrates of nicotine addiction 1998 (Cycle VII) $742,393
Scripps Research Institute Athina Markou Ph.D.
Neurobiological substrates of nicotine addiction 2001 (Cycle X) $402,852
Scripps Research Institute Athina Markou Ph.D.
Neuroendocrine responses to nicotine: a physiologic probe 1998 (Cycle VII) $225,000
University of California, San Francisco Lori Karan M.D.
Neuronal nicotinic receptor trafficking in nicotine addictio 2001 (Cycle X) $71,664
California Institute of Technology Raad Nashmi Ph.D.
Neuronal oxidative stress from mild carbon monoxide exposure 2005 (Cycle XIV) $418,972
University of California, Los Angeles John Edmond Ph.D.
Neuropharmacology of nicotine relapse 2003 (Cycle XII) $149,175
Cedars-Sinai Medical Center Xiu Liu M.D., Ph.D.
Neurotoxic effects of nicotine: anatomy, mechanisms, effects 1999 (Cycle VIII) $183,424
University of California, Los Angeles Gaylord Ellison Ph.D.
Neurotransmitter systems and tobacco smoking 1999 (Cycle VIII) $430,910
University of California, Los Angeles Richard Olmstead Ph.D.
New methods for searching tobacco industry documents 2003 (Cycle XII) $59,551
University of California, San Francisco Martha Michel M.S.
New therapy for lung cancer using radioiodide 2000 (Cycle IX) $225,000
University of California, Los Angeles Min Huang M.D., M.S.
Next Generation Califronai Tobacco Control Alliance 2003 (Cycle XII) $3,890
Next Generation Alliance Traci Verardo
NF-kB mediated inflammation in tobacco-induced lung cancer 2006 (Cycle XV) $420,000
University of California, San Diego Michael Karin Ph.D.
Nicotine & behavioral regulation in adult ADHD 2005 (Cycle XIV) $495,092
University of California, Irvine Jean-G. Gehricke Ph.D.
Nicotine & cardiac vulnerability to fibrillation 2000 (Cycle IX) $120,000
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
Nicotine & its metabolites: apoptosis in developing neurons 2000 (Cycle IX) $412,200
Human BioMolecular Research Institute Jun Zhang Ph.D.
Nicotine & Neuroendocrine Cell Signalling in Fetal Lung 1995 (Cycle IV) $349,873
University of Southern California Carol Wuenschell Ph.D.
Nicotine and cardiac vulnerability to fibrillation 2002 (Cycle XI) $641,821
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
Nicotine and cardiac vulnerability to fibrillation 1997 (Cycle VI) $370,057
Cedars-Sinai Medical Center Hrayr Karagueuzian Ph.D.
Nicotine and congenital heart disease 2008 (Cycle XVII) $629,797
Stanford University Ching-Pin Chang M.D., PH.D
Nicotine and Smoking Effects on Neuromuscular Development 1995 (Cycle IV) $412,639
Cedars-Sinai Medical Center Mario Fournier Ph.D.
Nicotine dependence & schizophrenia 2001 (Cycle X) $75,600
Scripps Research Institute Svetlana Semenova Ph.D.
Nicotine Disrupts PTHrP-Driven Paracrine Signaling Globally 2006 (Cycle XV) $133,126
LA Biomedical Research Institute at Harbor-UCLA Medical Center Virender Rehan M.D.
Nicotine effects on gene expression and metaplasticity 2004 (Cycle XIII) $74,500
Stanford University Damian Wheeler B.SC., Ph.D.
Nicotine effects on neurological development 1999 (Cycle VIII) $189,233
University of California, Irvine Raju Metherate Ph.D.
Nicotine effects on renal function in experimental diabetes 2000 (Cycle IX) $98,313
University of California, San Diego Francis Gabbai M.D.
Nicotine in the Brain 2000 (Cycle IX) $518,966
University of California, San Diego Darwin Berg Ph.D.
Nicotine May Affect Inflammation 1999 (Cycle VIII) $435,425
University of California, San Francisco Frederick Jia-Pei Miao M.D., Ph.D.
Nicotine Metabolism in Families 1998 (Cycle VII) $465,537
University of California, San Francisco Neal Benowitz M.D.
Nicotine modifies cardiac growth during adolescence 2007 (Cycle XVI) $138,600
Veterans Medical Research Foundation Wilbur Lew M.D.
Nicotine pharmacogenetics: influence of ethnicity 1997 (Cycle VI) $242,344
Cedars-Sinai Medical Center Russell Poland Ph.D.
Nicotine pharmacogenetics: influence of ethnicity 1997 (Cycle VI) $366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center Russell Poland Ph.D.
Nicotine Receptors: Role in Nicotine Addiction 2006 (Cycle XV) $20,748
California Institute of Technology Ryan Drenan Ph.D.
Nicotine recp mediated dopamine release and chronic nicotine 2006 (Cycle XV) $75,000
The Parkinson's Institute Xiomara Perez Ph.D.
Nicotine regulates cardiac toxicity with lipopolysaccharide 2000 (Cycle IX) $100,000
University of California, San Diego Wilbur Lew M.D.
Nicotine regulation of the noradrenergic system 2000 (Cycle IX) $52,375
University of California, Irvine Kathryn O'Leary M.S., Ph.D.
Nicotine replacement in school-based cessation 2000 (Cycle IX) $961,266
University of Southern California Clyde Dent Ph.D.
Nicotine replacement in school-based cessation 2000 (Cycle IX) $961,266
University of Southern California Rita Leeseman
Nicotine replacement therapy: pharmacists' counseling role 1998 (Cycle VII) $113,929
SRI International Karen Hudmon Dr.P.H., R.P.H., M.S.
Nicotine self-administration in an animal model 2003 (Cycle XII) $660,156
Scripps Research Institute George Koob Ph.D.
Nicotine Self-Administration in an Animal Model 2008 (Cycle XVII) $720,434
Scripps Research Institute George Koob Ph.D.
Nicotine synapse formation in the hippocampus 2005 (Cycle XIV) $59,500
University of California, San Diego Kerri Massey B.A.
Nicotine toxicity acting on cardiac neurons 1997 (Cycle VI) $446,920
University of California, San Diego Darwin Berg Ph.D.
Nicotine withdrawal, smoking & attention: an fMRI study 2001 (Cycle X) $515,303
University of California, Los Angeles Edythe London Ph.D.
Nicotine-dependent recruitment of vascular progenitor cells 2006 (Cycle XV) $799,907
The Burnham Institute for Medical Research William Stallcup Ph.D.
Nicotine-pathological angiogenesis and genetic determinants 2002 (Cycle XI) $608,420
Stanford University John Cooke M.D., Ph.D.
Nicotine's effects on uterine artery contractillity 2005 (Cycle XIV) $73,878
Loma Linda University DaLiao Xiao Ph.D.
Nicotinic and Schizophrenia 2000 (Cycle IX) $87,719
University of California, Irvine Ricardo Miledi M.D.
Nicotinic Manipulation of the Hippocampus 2007 (Cycle XVI) $420,000
University of California, San Diego Darwin Berg Ph.D.
Nicotinic modulation of dopamine release during development 1999 (Cycle VIII) $25,698
University of California, Irvine Layla Azam
Nicotinic receptors & synaptic aging 2001 (Cycle X) $224,973
University of California, San Diego Jay Coggan Ph.D.
Nicotinic receptors and Parkinson's disease 2002 (Cycle XI) $376,470
The Parkinson's Institute Maryka Quik Ph.D.
Nicotinic receptors at GABAergic synapses in the hippocampus 2004 (Cycle XIII) $75,000
University of California, San Diego Jingming Zhang Ph.D.
Nicotinic receptors in nicotine addiction 2008 (Cycle XVII) $634,779
California Institute of Technology Henry Lester Ph.D.
Nicotinic receptors on hippocampal neurons 2002 (Cycle XI) $69,940
University of California, San Diego Wagner Zago Ph.D.
Nicotinic receptors, smoking and Parkinson's Disease 2002 (Cycle XI) $765,971
Stanford University Lorene Nelson Ph.D.
Nicotinic Regulation of GABAergic Inhibition/Excitation 2008 (Cycle XVII) $75,000
University of California, San Diego Natalia Gounko Ph.D.
Nicotinic Regulation of GABAergic Signaling 2006 (Cycle XV) $70,120
University of California, San Diego Zhaoping Liu Ph.D.
Nicotinic Regulation of Neurogenesis in Adult Hippocampus 2008 (Cycle XVII) $60,000
University of California, San Diego Nolan Campbell B.S. Biology
Nicotonic receptors: role in addiction and reproduction 1997 (Cycle VI) $437,480
Salk Institute for Biological Studies Stephen Heinemann Ph.D.
Nitric oxide-dependent cell signaling in vascular cells 2000 (Cycle IX) $149,557
University of California, San Diego Tanima Gudi Ph.D.
Nitrogen Oxides and cigarette smoke-induced injury 1998 (Cycle VII) $304,118
University of California, Davis Albert van der Vliet Ph.D.
NMR studies of the LDL receptor active conformation of ApoE 2007 (Cycle XVI) $60,000
University of California, Berkeley Paul Hauser B.S.
NMR Study of 13C Edatrexate Metabolism 1995 (Cycle IV) $258,990
University of California, Davis Thomas Jue Ph.D.
Noninvasive imaging of early atherosclerosis 1997 (Cycle VI) $101,923
University of California, San Diego Sotirios Tsimikas M.D.
Nonsmokers helping smokers and the role of culture 2004 (Cycle XIII) $476,656
University of California, San Diego Shu-Hong Zhu Ph.D.
Novel agents for apoptosis of lung cancer 2002 (Cycle XI) $787,977
The Burnham Institute for Medical Research Xiao-Kun Zhang Ph.D.
Novel Approaches to Lung Cancer Research 2006 (Cycle XV) $189,486
The Burnham Institute for Medical Research Kristiina Vuori M.D., Ph.D.
Novel Cationic Polymers for RNAi Delivery in NSCLC Treatment 2007 (Cycle XVI) $75,000
University of California, Irvine Lai Chu Lin Ph.D.
Novel DNA vaccines for the treatment of lung cancer 2000 (Cycle IX) $1,063,300
Scripps Research Institute Ralph Reisfeld Ph.D.
Novel DNA vaccines for the treatment of lung cancer 2003 (Cycle XII) $783,900
Scripps Research Institute Ralph Reisfeld Ph.D.
Novel Extracellular Sulfatases and Smoke-induced Lung Cancer 2008 (Cycle XVII) $394,380
University of California, San Francisco Steven Rosen Ph.D.
Novel imaging methods for diagnosing tobacco related cancers 1997 (Cycle VI) $629,087
Stanford University Albert Macovski Ph.D.
Novel nicotine cessation therapeutics 2000 (Cycle IX) $802,840
Human BioMolecular Research Institute John Cashman Ph.D.
Novel Office-Based Device for Imaging Vocal Cord Cancer 2003 (Cycle XII) $510,000
University of California, Irvine Brian Wong M.D., Ph.D.
Novel regulatory mechanisms for lung cancer growth 2000 (Cycle IX) $100,000
University of California, San Diego Randolph Hastings M.D., Ph.D.
Novel regulatory mechanisms for lung cancer growth 2001 (Cycle X) $620,032
Veterans Medical Research Foundation Randolph Hastings M.D., Ph.D.
Novel strategy for protecting neurons from injury in stroke 1999 (Cycle VIII) $742,809
Stanford University Robert Sapolsky Ph.D.
Novel therapy for pancreatic cancer 1997 (Cycle VI) $452,332
University of California, Irvine Hung Fan Ph.D.
NRT and paroxetine for smoking cessation 1997 (Cycle VI) $646,916
Stanford University Joel Killen Ph.D.
Oral clefts, smoking & variation of toxin biotransformation 2004 (Cycle XIII) $623,472
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Oral clefts, smoking & variation toxin biotransformation 1997 (Cycle VI) $677,128
Children's Hospital Oakland Research Institute Edward Lammer M.D.
Overcoming drug resistance in small cell lung cancer 2001 (Cycle X) $141,340
The Burnham Institute for Medical Research Kristiina Vuori M.D., Ph.D.
Oxidative damage to sperm DNA: smoking and diet interaction 1998 (Cycle VII) $155,135
University of California, Berkeley Bruce Ames Ph.D.
Oxidative damage to sperm DNA: smoking and diet interaction 1998 (Cycle VII) $132,367
Children's Hospital Oakland Research Institute Bruce Ames Ph.D.
Oxidative stress and skeletal muscle dysfunction in COPD 2006 (Cycle XV) $555,000
University of California, San Diego Russell Richardson Ph.D.
Oxidized lipids and programmed cell death in atherosclerosis 1999 (Cycle VIII) $69,116
University of California, San Diego Mi-Kyung Chang M.D.
Oxygen Club of California 2007 (Cycle XVI) $5,000
Oxygen Club John Maguire DDS
Oxygen Club of California 2003 (Cycle XII) $5,000
Oxygen Club John Maguire DDS
Oxygen Club of California 2005 (Cycle XIV) $5,000
Oxygen Club John Maguire DDS
Oxygen radicals in biology GRC 2006 2005 (Cycle XIV) $5,000
University of California, Merced Henry Forman Ph.D.
Oxygen Radicals in Biology GRC2008 2007 (Cycle XVI) $5,000
University of Southern California Enrique Cadenas Ph.D.
Oxygen Transport Following Lung Transplantation in COPD 2007 (Cycle XVI) $74,500
University of California, San Diego Moh Malek Ph.D.
Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation 2007 (Cycle XVI) $260,203
University of California, Davis Ayala Luria Ph.D.
p53 and p14ARF: Multiple pathways of lung cancer suppression 2002 (Cycle XI) $821,050
Sidney Kimmel Cancer Center Ruth Gjerset Ph.D.
p53 Mutations in Sporadic & Familial Childhood Tumors 1994 (Cycle III) $213,407
University of California, Davis Sara Bodner M.D.
Pager-assisted smoking cessation treatment 2002 (Cycle XI) $463,689
University of California, San Francisco Timothy Carmody Ph.D.
Pager-cued therapeutic messages for smoking cessation 1999 (Cycle VIII) $74,889
University of California, San Francisco Timothy Carmody Ph.D.
Parental and Movie Influences on Adolescent Smoking Behavior 1999 (Cycle VIII) $50,793
University of California, San Diego Janet Distefan Ph.D.
Parkinson's Disease: A Protective Effect of Smoking? 1999 (Cycle VIII) $512,849
Stanford University Lorene Nelson Ph.D.
Partnering for tobacco control research among deaf youth 1999 (Cycle VIII) $75,000
University of California, Los Angeles Heidi Kleiger B.S.
Partnering for tobacco control research among deaf youth 1999 (Cycle VIII) $75,000
University of California, Los Angeles Barbara Berman Ph.D.
Partnership to promote smoking cessation in older adults 2002 (Cycle XI) $101,367
Institute on Aging Sharon Hall Ph.D.
Partnership to promote smoking cessation in older adults 2002 (Cycle XI) $101,367
Institute on Aging Glenna Dowling Ph.D., R.N.
Partnerships to reduce smoking among the LGBT community 2000 (Cycle IX) $73,981
University of California, San Francisco Greg Greenwood Ph.D.
Partnerships to reduce smoking among the LGBT community 2000 (Cycle IX) $73,981
University of California, San Francisco Nancy Ferreyra
Passive Smoking and Clara Cell Development in the Lungs 1995 (Cycle IV) $442,317
University of California, Davis Kent Pinkerton Ph.D.
Passive smoking, inflammatory markers and childhood asthma 2003 (Cycle XII) $508,299
University of California, San Diego Hillary Klonoff-Cohen Ph.D.
Passive smoking, metabolizing genes and female lung cancer 1998 (Cycle VII) $111,740
Childrens Hospital, Los Angeles Jan Van Tornout M.D., M.S.
Passive Smoking: Role of Airways Reactivity in Infancy 1995 (Cycle IV) $486,888
University of California, Berkeley Ira Tager M.D., M.P.H.
Pathophysiology of abnormal remnant metabolism in smokers 2000 (Cycle IX) $783,345
Palo Alto Medical Foundation Research Institute Allen Cooper M.D.
Pathways of catabolism of oxidized phospholipids 2001 (Cycle X) $225,000
University of California, San Diego Peter Friedman Ph.D.
Pathways of how socioeconomic context affects teen smoking 2006 (Cycle XV) $75,000
University of California, Los Angeles Ritesh Mistry Ph.D. M.P.A.
Patterns & risk factors for adolescent smoking progression 2000 (Cycle IX) $47,521
University of Southern California Chaoyang Li MPH
Patterns of tobacco use from adolescence to young adulthood 1997 (Cycle VI) $565,277
RAND Corporation Phyllis Ellickson Ph.D.
Patterns of tobacco use from adolescence to young adulthood 2001 (Cycle X) $431,132
RAND Corporation Phyllis Ellickson Ph.D.
Pediatrician training to prevent children's tobacco exposure 1997 (Cycle VI) $133,852